Prioritization of research addressing management strategies for ductal carcinoma in situ.

Published

Journal Article

Ductal carcinoma in situ is a common finding in women having mammography screening, and there is considerable uncertainty about the balance of harms and benefits of different management options. This article outlines the process for developing a prioritized research agenda for the Patient-Centered Outcomes Research Institute as informed by a diverse group of stakeholders on the management of ductal carcinoma in situ. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to refine these gaps. Stakeholders ranked evidence gaps by importance from their perspectives using a forced-ranking prioritization method. PubMed was searched for relevant recent studies, and ClinicalTrials.gov was searched for relevant ongoing trials for the 10 highest-ranked evidence gaps. Strengths and limitations of different study designs were assessed to address gaps. Stakeholders prioritized evidence gaps related to incorporation of patient-centered outcomes into future research, development of better methods to predict risk for invasive cancer, evaluation of a strategy of active surveillance, and testing of decision-making tools. The degree to which prioritized evidence gaps may have already been addressed is uncertain because a comprehensive systematic review has not been done.

Full Text

Duke Authors

Cited Authors

  • Gierisch, JM; Myers, ER; Schmit, KM; Crowley, MJ; McCrory, DC; Chatterjee, R; Coeytaux, RR; Kendrick, A; Sanders, GD

Published Date

  • April 1, 2014

Published In

Volume / Issue

  • 160 / 7

Start / End Page

  • 484 - 491

PubMed ID

  • 24567146

Pubmed Central ID

  • 24567146

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/M13-2548

Language

  • eng

Conference Location

  • United States